Hepatitis C

Study to Assess Efficacy and Safety of Grazoprevir/Elbasvir Associated With Sofosbuvir and Ribavirin in HCV Genotype 1 or 4-infected Patients Who Failed Direct Acting Antivirals (DAA) Bitherapy With Sofosbuvir

Feasibility and Acceptability of HCV Treatment in Pregnancy

Study of the Pharmacokinetics and Safety of Glecaprevir/Pibrentasvir Initiated in Pregnancy in Women With Hepatitis C With and Without HIV

DBS TaT in Peer-assisted Telemedicine for Hepatitis C

Enhancing Hepatitis C Testing and Treatment Among People Who Inject Drugs Attending Needle and Syringe Programs

Treatment of HOsPitalised Inpatients for Hepatitis C (TOPIC): Therapeutic Intervention Enhancing Care Linkage in People Who Inject Drugs

Evaluation of Patients With Liver Disease

Epidemiology, Infectivity and Natural History of Hepatitis C Virus Infection

Proteogenomic Monitoring and Assessment of Liver Transplant Recipients

Tele-Harm Reduction

Mobile Enhanced Prevention Support for People Leaving Jail

Hepatitis C Screening Paired With Mammography

ETHOS ENGAGE: Enhancing Treatment of Hepatitis C in Opioid Substitution Settings

Lung Transplant HCV, Pilot Study

A Phase 1 Clinical Trial of Adjuvanted Protein-based HCV Vaccine Candidates (HCV Vaccine Trial)

The Use of Hepatitis C Positive Livers in Hepatitis C Negative Liver Transplant Recipients

Hepatitis B and Hepatitis C as Risk Factors for Hepatocellular Carcinoma in African and Asian Immigrants

Advanced Care Coordination and Enhanced Linkage and Retention Among Transitional Re-Entrants

C-Forward: Efficacy and Safety of BEM/RZR vs SOF/VEL in Subjects With Chronic HCV

The Australian HCV Point-of-Care Testing Program